Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Brain Res Bull ; 134: 228-235, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28802897

RESUMEN

Lithium (Li) is a mood-stabilizing drug used in the treatment of bipolar disorder (BD). Recently, preclinical studies have demonstrated the potential of tamoxifen (TMX) in the treatment of acute episodes of BD. However, the prolonged use of TMX for mood disorders treatment is controversial. In this study, we evaluated the effects of TMX or Li on cognitive behavior, as well as the levels of neurotrophic factors in the brain of male and female rats. Male and female Wistar rats received administrations of water (control group), TMX or Li via gavage for a period of 28days; the rats were then subjected to the open-field test (to evaluate spontaneous locomotion), and the novel object recognition and step-down inhibitory avoidance tests (to evaluate cognition). The levels of NGF, BDNF and GDNF were evaluated in the hippocampus and frontal cortex of the subject rats. No significant differences were observed in the open-field and inhibitory avoidance tests after drug administration in either the male or female rats. The administration of TMX, but not Li, decreased the recognition index of both the male and female rats in the object recognition test. The chronic administration of TMX decreased, whereas Li increased the levels of BDNF in the hippocampus of both the male and female rats. Tamoxifen decreased the levels of NGF in the hippocampus of female rats. In conclusion, it can be suggested that long-term treatments with TMX can lead to significant cognitive impairments by reducing the levels of neurotrophic factors in the brain of rats.


Asunto(s)
Encéfalo/efectos de los fármacos , Carbonato de Litio/efectos adversos , Memoria/efectos de los fármacos , Psicotrópicos/efectos adversos , Tamoxifeno/efectos adversos , Animales , Reacción de Prevención/efectos de los fármacos , Reacción de Prevención/fisiología , Encéfalo/metabolismo , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Cognición/efectos de los fármacos , Cognición/fisiología , Conducta Exploratoria/efectos de los fármacos , Conducta Exploratoria/fisiología , Femenino , Factor Neurotrófico Derivado de la Línea Celular Glial/metabolismo , Masculino , Memoria/fisiología , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/metabolismo , Actividad Motora/efectos de los fármacos , Actividad Motora/fisiología , Factor de Crecimiento Nervioso/metabolismo , Distribución Aleatoria , Ratas Wistar
2.
ACM arq. catarin. med ; 41(2)abr.-mar. 2012. tab
Artículo en Portugués | LILACS | ID: lil-664838

RESUMEN

Introdução: Comorbidades psiquiátricas em pacientescom transtorno bipolar se revelam muito frequentese esta coocorrência está associada com efeitos negativossobre o curso e prognóstico da doença. Objetivos:Conhecer a prevalência de comorbidades psiquiátricase sua relação com as características do transtorno bipolartipo I, em pacientes atendidos no ambulatório depesquisa. Metodologia: Realizamos um estudo exploratório,transversal, observacional e prospectivo, no períodode fevereiro a setembro de 2011. A amostra foicomposta por 24 pacientes diagnosticados com transtornobipolar tipo I avaliados quanto à comorbidadespsiquiátricas através da Entrevista Clínica Estruturadapara Transtornos do Eixo I do DSM-IV, enquanto os outrosdados clínicos dos pacientes foram avaliados porquestionários aplicados, a fim de caracterizar a doença.Resultados: A maioria dos pacientes (62,5%) fechavacritérios diagnósticos para pelo menos uma comorbidade,sendo mais comum a coocorrência de uma ou maiscomorbidades passadas (58,3%) que as atuais (37,5%).Os transtornos de ansiedade se mostraram os mais prevalentes(45,8%), seguidos por transtornos do uso desubstâncias (25,0%), somatoformes (16,7%) e alimentares(4,2%). A associação entre o curso da doença e apresença de comorbidades psiquiátricas não apresentaramrelação significativa. Conclusão: Este estudo mostrouque pacientes bipolares possuem alta prevalênciade comorbidades psiquiátricas do eixo I do DSM-IV,sendo mais comuns os transtornos ansiosos e por usode substâncias, consoante ao encontrado em estudosanteriores. No entanto, diferindo da literatura a relaçãoentre as características da evolução do transtorno bipolare a ocorrência de comorbidades não apresentoudiferença significativa.


Background: Psychiatric comorbidities in patientswith bipolar disorder to reveal a high frequent and thisco-occurrence is associated with negative effects onthe course and prognosis of this pathology. Objective:Know what is the prevalence of psychiatric comorbiditiesand their relation with the characteristics of bipolardisorder type I in patients attended in outpatient clinicof research in the UNESC. Methods: This study was conductedas exploratory, transversal, observational andprospective, in the period from February to September2011. The sample is composed for 24 patients diagnosedwith bipolar disorder I and assessed for psychiatriccomorbidity, through the Structured Clinical Interviewfor Axis I of DSM-IV, as well was applied questionnairesin order to obtain the characteristics of disease. Results:The majority of bipolar patients (62.5%) had diagnosticcriteria closed at least one comorbidity, and the co-occurrenceof one or more longtime comorbidities weremost common (58.3%) than with the current (37.5%).Anxiety disturbances were the most prevalent (45.8%),followed by use of substance disturbance (25.0%), somatoform(16.7%) and eating disorder (4.2%). The relationshipbetween the course of disease and the presenceof psychiatric comorbidities were not significant.Conclusions: Patients with bipolar disorder have a highprevalence of psychiatric comorbid based in Axis I ofDSM-IV, the most common disorders are anxiety andsubstance use. The relationship between the characteristicsof evolution of disease and the occurrence ofcomorbidities did not show different significant.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA